Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Novartis AG ADS (NY: NVS)
74.63 USD  +0.47 (+0.63%)
Official Closing Price  /  Updated: 4:15 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Blog posts about Novartis AG ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
This Tiny Startup Has Scored "Microchip Medicine" Breakthrough
August 09, 2012
About the Author Michael A. Robinson is one of the top financial analysts working today. His 30-year track record as a leading tech analyst has garnered him rave reviews. The first analyst to uncover... Read More
category Stocks
from Money Morning
Buyers Stepping In - Novartis
August 03, 2012
New York, August 3rd (TradersHuddle.com) - Unusual high volume detected on shares of Novartis AG ( NYSE:NVS ) early in the trading session. The pace in volume of Novartis is already above average, with... Read More
from TradersHuddle.com
Novartis Above Average Volume
August 01, 2012
New York, August 1st (TradersHuddle.com) - Unusual high volume detected on shares of Novartis AG ( NYSE:NVS ) early in the trading session. The pace in volume of Novartis is already above average, with... Read More
from TradersHuddle.com
High Above Average Volume on Novartis
July 25, 2012
New York, July 25th (TradersHuddle.com) - Unusual high volume detected on shares of Novartis AG ( NYSE:NVS ) early in the trading session. The pace in volume of Novartis points to a break above... Read More
from TradersHuddle.com
Sellers in Control - Novartis
July 24, 2012
New York, July 24th (TradersHuddle.com) - Unusual high volume detected on shares of Novartis AG ( NYSE:NVS ) early in the trading session. The pace in volume of Novartis points to a break above... Read More
from TradersHuddle.com
Hot Option Plays: Stocks Hold Gains
July 18, 2012
Cusick’s Corner 07-18-2012 I am going to make it short today, trying to get out early on a flight because there’s bad weather in the Midwest. The bid could not muster much more momentum into the close... Read More
category Options , FCX , ALU , and 12 more.
from DailyMarkets.com
Hot Option Plays: Market 3 Days In The Green
July 03, 2012
Cusick’s Corner 07-03-2012 The bulls held control over the last three sessions, maybe a little overbought going into the holiday. This could lead to some potentially interesting trading into the end of... Read More
category Options , SPY , hd , and 11 more.
from DailyMarkets.com
(ARE) Alexandria Real Estate Equities Sees New Lease Agreements
June 10, 2012
Alexandria Real Estate Equities, Inc. (ARE), a real estate investment trust (REIT), recently... Visit StockBlogHub to view complete post. Read More
category TMO , SNTA , Glaxosmithkline plc , and 19 more.
from Stock Blog Hub
Hot Option Plays: Will Fatigue Kick In?
May 30, 2012
Cusick Corner 05-30-2012 Weakness begets Weakness, and the ugliest of them all is the Euro Currency, FXE, which is a tough short at these levels and hard to play for a bounce as well. It’s also tough... Read More
category QQQ , Options , GME , and 10 more.
from DailyMarkets.com
Biogen Tysabri Canadian Label Update
May 25, 2012
Biogen Idec (NASDAQ:BIIB) recently announced that Health Canada has approved a change in the label of its multiple sclerosis (MS) drug, Tysabri. The new label of the drug indicates anti-JC virus (JCV)... Read More
category NVS , TEVA , Stocks , and 4 more.
from DailyMarkets.com
Gen-Probe Remains Neutral
May 25, 2012
We reiterate our Neutral rating on Gen-Probe Inc. (NASDAQ:GPRO). Its first-quarter 2012 adjusted earnings of 55 cents per share beat the Zacks Consensus Estimate of 51 cents. Revenues of $153.4 million... Read More
category RHHBY , HOLX , External Research , and 6 more.
from DailyMarkets.com
Incyte Stays Neutral
May 24, 2012
We are maintaining our Neutral recommendation on Incyte Corporation (NASDAQ:INCY) with a target price of $23.00. This is in line with the Zacks #3 Rank (Hold rating) carried by the stock in the short... Read More
category NVS , INCY , Stocks , and 3 more.
from DailyMarkets.com
Incyte Stays Neutral
May 24, 2012
We are maintaining our Neutral recommendation on Incyte Corporation (NASDAQ:INCY) with a target price of $23.00. This is in line with the Zacks #3 Rank (Hold rating) carried by the stock in the short... Read More
category NVS , INCY , Stocks , and 3 more.
from DailyMarkets.com
Shire Presents Data On Venvanse
May 24, 2012
Shire (NASDAQ:SHPGY) recently presented positive results on Venvanse (lisdexamfetamine dimesylate) from a phase III study at the EUNETHYDIS 2nd International Attention-Deficit/Hyperactivity Disorder... Read More
category NVS , SHPGY , jnj , and 5 more.
from DailyMarkets.com
Perrigo’s Generic Portfolio Boosted
May 23, 2012
Good news flowed in at  Perrigo Company (NASDAQ:PRGO) when the U.S. Food and Drug Administration (FDA) cleared its generic version of KV Pharmaceutical Company’s vaginal cream Gynazole·1. Final... Read More
category NVS , PRGO , Stocks , and 2 more.
from DailyMarkets.com
Good News For Perrigo
May 21, 2012
Perrigo Company (NASDAQ:PRGO) recently received some good news when the U.S. Food and Drug Administration (FDA) cleared its generic version of Novartis’ (NYSE:NVS) heart burn drug Prevacid. Approval... Read More
category NVS , PRGO , Stocks , and 2 more.
from DailyMarkets.com
RDY Adds To Generic Portfolio
May 21, 2012
Dr. Reddy’s Laboratories (NYSE:RDY) has been busy launching generics and the recent U.S. launch of a generic version of Novatis AG’s (NYSE:NVS) over-the-counter (OTC) drug, Prevacid, was the second one... Read More
category RDY , NVS , Stocks , and 3 more.
from DailyMarkets.com
Novartis Progresses With NVA237
May 21, 2012
Switzerland-based pharmaceutical company, Novartis AG (NYSE:NVS) recently announced positive phase III data from the GLOW 2 study of its pipeline candidate NVA237. The candidate is being studied for... Read More
category NVS , ESALY , Stocks , and 2 more.
from DailyMarkets.com
Positive Data On Novartis’ Lucentis
May 15, 2012
Switzerland-based pharmaceutical company, Novartis AG (NYSE:NVS) recently announced that positive data on Lucentis was presented at the annual meeting of the Association for Research in Vision and... Read More
category NVS , RHHBY , Stocks , and 2 more.
from DailyMarkets.com
Standard Review For Biogen’s BG-12
May 11, 2012
Biogen Idec (NASDAQ:BIIB) recently announced the acceptance of its regulatory filings in the U.S. and E.U. for its oral multiple sclerosis candidate, BG-12. The U.S. Food and Drug Administration (FDA)... Read More
category NVS , Stocks , External Research , and 3 more.
from DailyMarkets.com
FDA Approves Gen-Probe’s PANTHER
May 11, 2012
Gen-Probe Inc. (NASDAQ:GPRO), a leading diagnostic devices company, recently announced the approval of the U.S. Food and Drug Administration (“FDA”) for its PANTHER system, an immunoassay instrument... Read More
category RHHBY , External Research , Contributor , and 5 more.
from DailyMarkets.com
PetMed Express Remains Neutral
May 11, 2012
We have reaffirmed our Neutral recommendation on PetMed Express (NASDAQ:PETS), following its fourth quarter and fiscal 2012 results. PetMed reported $55.9 million as revenues during the fourth quarter... Read More
category PETM , NVS , PETS , and 3 more.
from DailyMarkets.com
New Ratings: NVS, SNY, CYS
May 10, 2012
New York, May 10th (TradersHuddle.com) - Following are some of the new analyst ratings before the market open. Novartis ( NYSE:NVS ) was initiated with a Buy at Societe Generale. Sanofi-Avent. Read... Read More
from TradersHuddle.com
Investing in Emerging Markets with U.S.-Traded ADRs
May 07, 2012
For most of the past decade, the name of the game in worldwide equities has been investing in emerging markets. If you don't believe me, just take a look at the performance of the iShares MSCI Emerging... Read More
category emerging markets countries , emerging markets 2011 , list of emerging markets , and 7 more.
from Money Morning
Bulls taking Control of Novartis?
April 26, 2012
New York, April 26th (TradersHuddle.com) - Shares of Novartis AG ( NYSE:NVS ) ended the trading session higher by $0.03 or 0.05% from its previous close. Novartis' price action formed what is... Read More
from TradersHuddle.com
Disappointing Results At Novartis
April 25, 2012
Swiss pharmaceutical giant Novartis (NYSE:NVS) reported earnings per share of $1.27 for the first quarter of 2012, missing the Zacks Consensus Estimate by $0.05. Earnings were 10% below the year-ago... Read More
category NVS , Stocks , External Research , and 2 more.
from DailyMarkets.com
Bulls and Bears on the Trenches of Novartis
April 24, 2012
New York, April 24th (TradersHuddle.com) - Shares of Novartis AG ( NYSE:NVS ) closed the trading day lower by $0.68 or -1.21% from its previous close. Novartis' price action formed what is considered... Read More
from TradersHuddle.com
2012 ASCO Conference Stocks
April 20, 2012
Analyst Ian Cooper takes a look at some of the top presenters at this year's 2012 ASCO conference and offers a few ways to trade the event. Read More
from Wealth Daily
Biogen’s Fampyra Launched In Canada
April 13, 2012
Biogen Idec (NASDAQ:BIIB) recently announced the launch of Fampyra in Canada. Fampyra gained approval in Canada in February 2012 for the symptomatic improvement of walking ability in adult multiple... Read More
category TEVA , External Research , Contributor , and 8 more.
from DailyMarkets.com
FDA Clears Cooper Avaira Toric
April 12, 2012
CooperVision, a segment of The Cooper Companies (NYSE:COO), a company dedicated to contact lens and women’s health, recently revealed that the Food and Drug Administration (“FDA”) has granted a Special... Read More
category NVS , jnj , COO , and 3 more.
from DailyMarkets.com
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here